|
FertiCare® was developed by Multicept, in cooperation with specialists at Righospitalet (The
University Hospital pf Copenhagen, Denmark)
This hand-held vibrator works by using a simple technique called Transcutaneous
Mechanical Nerve Stimulation (TMNS). It is easy and above all, safe to use.
Stress Urinary Incontinence (SUI) is a prevalent problem.
Recent studies have indicated that 1 out of 4 women over 20 years of age experience incontinence. Treatment of SUI has been
varied and ranges from simple containment (diapers, etc.) without specific treatment of the condition, to Kegel exercises
to re-train the pelvic floor muscles, and surgical procedures such as suspensions and sling operations. Unfortunately,
since Kegel exercise efficacy is so low, this type of therapy leaves much to be desired. Surgical sling procedures are effective
with a high dress of satisfaction, but the treatment is invasive.
In clinical studies, after just six weeks using TMNS once a week, subjects
reported a significant reduction in the number of incontinence episodes. Of the 33 subjects, 24 (73%) were cured and 29 (88%)
were condition improved. Additionally, the Journal of the American Medical Association reported in 1998 that 43% of women
of all ages experience sexual dysfunction. Medications prescribed for depression related to this condition further diminishes
sex drive. In conclusion, the TMNS offers women who suffer from sexual dysfunction or incontinence a drug-free, non-invasive
alternative to achieve Kegel stimulating exercise in the privacy of your own home! Urinary incontinence is an important problem in society. In a large recent study Hannestad et al surveyed 27,936
women older than 20 years and found an overall incidence of incontinence of 25%. In a meta-analysis Minassian et al calculated
a rate of 27.6%. Estimates from epidemiological studies vary widely depending on the definition of incontinence, the
age of the patient population studied and the methodology applied to the studies. Hannestad et al determined that 20-year-old
women experienced a prevalence of 10% vs 35% of women older than 85 years. Stenzelius et al found that more than 39% of women
older than 74 years were incontinent. The financial burden
of incontinence on the patient and the health care insurance system is substantial. After a diagnosis of stress urinary incontinence
there was doubling of health care costs for subjects undergoing nonsurgical treatment ($4,478 vs $9,147) and a tripling of
total health care costs for those undergoing surgical treatment ($4,475 vs $14,129). The lifetime total cost of treating stress
urinary incontinence has been estimated to be $58,000. Stress urinary incontinence in women represents 50% to 77% of all cases
of urinary incontinence. The condition can be caused by poor pelvic floor support leading to hypermobility of the bladder
neck and change in the intra-abdominal influence on urethral closing pressure. Intrinsic sphincter deficiency
can also lead to stress incontinence even without hypermobility due to inability of the internal sphincter to generate a sufficient
closing pressure to maintain urinary control. Often both of these patterns exist in the same patient. Treatment of SUI has been varied and ranges from simple containment (diapers, etc) without specific treatment
of the condition, to Kegel exercises to retrain the pelvic floor muscles, and surgical procedures such as suspensions
and sling operations. Unfortunately, since Kegel exercise efficacy is so low, this type of therapy leaves much to be
desired. This cure rate with Kegel exercises has been estimated to be 12% to 18%. Surgical sling procedures are effective
with a high degree of satisfaction, but the treatment is invasive and has potential complications such as the need for intermittent
catheterization or urethrolysis to empty the bladder due to obstructive post operative urinary retention. There is a great
need for the development of an effective, safe and noninvasive therapy for this condition.
|
